연구동향 분석

다제내성결핵균에서 유전자 변이분석을 이용한 퀴놀론 내성검출의 유용성 평가

김창기 이병수 최명준 김희진 이경원 2014년

논문상세정보
인용/피인용
' 다제내성결핵균에서 유전자 변이분석을 이용한 퀴놀론 내성검출의 유용성 평가' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 미생물학
  • fluoroquinolone
  • gyra
  • gyrb
  • multidrug-resistant tuberculosis
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
182 0

0.0%

' 다제내성결핵균에서 유전자 변이분석을 이용한 퀴놀론 내성검출의 유용성 평가' 의 참고문헌

  • Trend of anti-tuberculosis drug resistance in Korea, 1994-2004
    Bai GH Int J Tuberc Lung Dis 11 571-576 [2007]
  • Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis
    Johnston JC PLoS One 4 e6914- [2009]
  • Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis
    Kwon YS Clin Infect Dis 47 496-502 [2008]
  • The National Status of Tuberculosis Using Nationwide Medical Records Survey of Patients with Tuberculosis in Korea
    Yoon-Sung Park Tuberculosis and Respiratory Diseases 73 1 48-55 [2012]
  • Susceptibility testing of mycobacteria, Nocardiae, and other aerobic actinomycetes
    CLSI. - [2011]
  • Stepwise decrease in moxifloxacin susceptibility amongst clinical isolates of multidrug-resistant Mycobacterium tuberculosis: correlation with ofloxacin susceptibility
    Kam KM Microb Drug Resist 12 7-11 [2006]
  • Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa
    Barnard M Am J Respir Crit Care Med 177 787-792 [2008]
  • Rapid molecular detection of tuberculosis and rifampin resistance
    Boehme CC N Engl J Med 363 1005-1015 [2010]
  • Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis
    Huang WL J Clin Microbiol 49 2502-2508 [2011]
  • Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis
    Campbell PJ Antimicrob Agents Chemother 55 2032-2041 [2011]
  • Global tuberculosis control: WHO report 2012
    WHO. - [2012]
  • Fluoroquinolone resistance in Mycobacterium tuberculosis:the effect of duration and timing of fluoroquinolone exposure
    Devasia RA Am J Respir Crit Care Med 180 365-370 [2009]
  • Fluoroquinolone resistance in Mycobacterium tuberculosis. What have we learnt?
    Yew WW Int J Tuberc Lung Dis 18 1-2 [2014]
  • Fluoroquinolone resistance in Mycobacterium tuberculosis isolates:associated genetic mutations and relationship to antimicrobial exposure
    Wang JY J Antimicrob Chemother 59 860-865 [2007]
  • Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens
    Hillemann D J Clin Microbiol 47 1767-1772 [2009]
  • Evaluation of the MTBDRsl test for detection of secondline-drug resistance in Mycobacterium tuberculosis
    Kiet VS J Clin Microbiol 48 2934-2939 [2010]
  • Drug-susceptibility testing in tuberculosis: methods and reliability of results
    Kim SJ. Eur Respir J 25 564-569 [2005]
  • Detection of multidrug resistance in Mycobacterium tuberculosis
    Sekiguchi J J Clin Microbiol 45 179-192 [2007]
  • Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates
    Brossier F J Clin Microbiol 48 1683-1689 [2010]
  • Comparative study on genotypic and phenotypic second-line drug resistance testing of Mycobacterium tuberculosis complex isolates
    van Ingen J J Clin Microbiol 48 2749-2753 [2010]
  • A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system
    Maruri F J Antimicrob Chemother 67 819-831 [2012]